Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project
Karen Ritchie, Michael T. Ropacki, Bruce Albala, et al.
Alzheimer s & Dementia (2016) Vol. 13, Iss. 2, pp. 186-195
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang, Alberto J. Espay
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 660-677
Open Access | Times Cited: 319
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M. Alexander, Sujuan Ba, Mitchel S. Berger, et al.
Clinical Cancer Research (2017) Vol. 24, Iss. 4, pp. 737-743
Open Access | Times Cited: 189
Cognitive Impairment Associated with Cancer: A Brief Review.
J. Cara Pendergrass, Steven D. Targum, John Harrison
Innovations in clinical neuroscience (2018) Vol. 15, Iss. 1-2, pp. 36-44
Closed Access | Times Cited: 180
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
Rasha N.M. Saleh, Michael Hornberger, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 89
APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
M Clare O'Donoghue, Susannah E. Murphy, Giovanna Zamboni, et al.
Cortex (2018) Vol. 104, pp. 103-123
Open Access | Times Cited: 159
Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Harald Hampel, Nicola Toschi, Claudio Babiloni, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S47-S105
Open Access | Times Cited: 139
Speech Analysis by Natural Language Processing Techniques: A Possible Tool for Very Early Detection of Cognitive Decline?
Daniela Beltrami, Gloria Gagliardi, Rema Rossini Favretti, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 135
Measuring cognition and function in the preclinical stage of Alzheimer's disease
Sandra Weıntraub, María C. Carrillo, Sarah Tomaszewski Farias, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2018) Vol. 4, Iss. 1, pp. 64-75
Open Access | Times Cited: 106
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
Alina Solomon, Miia Kivipelto, José Luís Molinuevo, et al.
BMJ Open (2018) Vol. 8, Iss. 12, pp. e021017-e021017
Open Access | Times Cited: 91
The Alzheimer Precision Medicine Initiative
Harald Hampel, Andrea Vergallo, George Perry, et al.
Journal of Alzheimer s Disease (2019) Vol. 68, Iss. 1, pp. 1-24
Closed Access | Times Cited: 85
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
André Strydom, Antonia Coppus, Rafael Blesa, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2018) Vol. 4, Iss. 1, pp. 703-713
Open Access | Times Cited: 84
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
Silvia Ingala, Casper de Boer, Larissa A Masselink, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 7, pp. 1189-1204
Open Access | Times Cited: 62
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer’s disease
Jessica Nicosia, Andrew J. Aschenbrenner, David A. Balota, et al.
Journal of the International Neuropsychological Society (2022) Vol. 29, Iss. 5, pp. 459-471
Open Access | Times Cited: 57
FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
Marwan N. Sabbagh, Suzanne Hendrix, John Harrison
Alzheimer s & Dementia Translational Research & Clinical Interventions (2018) Vol. 5, Iss. 1, pp. 13-19
Open Access | Times Cited: 78
Composite cognitive and functional measures for early stage Alzheimer's disease trials
Lon S. Schneider, Terry E. Goldberg
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Linguistic features and automatic classifiers for identifying mild cognitive impairment and dementia
Laura Calzà, Gloria Gagliardi, Rema Rossini Favretti, et al.
Computer Speech & Language (2020) Vol. 65, pp. 101113-101113
Open Access | Times Cited: 58
Developing an Explainable Machine Learning-Based Personalised Dementia Risk Prediction Model: A Transfer Learning Approach With Ensemble Learning Algorithms
Samuel Danso, Zhanhang Zeng, Graciela Muñiz‐Terrera, et al.
Frontiers in Big Data (2021) Vol. 4
Open Access | Times Cited: 50
The Australian Traumatic Brain Injury Initiative: Statement of Working Principles and Rapid Review of Methods to Define Data Dictionaries for Neurological Conditions
Matthew K. Bagg, Amelia J. Hicks, Sarah C. Hellewell, et al.
Neurotrauma Reports (2024) Vol. 5, Iss. 1, pp. 424-447
Open Access | Times Cited: 6
Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer’s Disease: The PREVENT Dementia Study
Karen Ritchie, Isabelle Carrière, David Howett, et al.
Journal of Alzheimer s Disease (2018) Vol. 65, Iss. 3, pp. 885-896
Open Access | Times Cited: 57
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Mara ten Kate, Silvia Ingala, Adam J. Schwarz, et al.
Alzheimer s Research & Therapy (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 55
THE EUROPEAN PREVENTION OF ALZHEIMER’S DEMENTIA (EPAD) LONGITUDINAL COHORT STUDY: BASELINE DATA RELEASE V500.0
C.W. Ritchie, Graciela Muñiz‐Terrera, Miia Kivipelto, et al.
The Journal of Prevention of Alzheimer s Disease (2019), pp. 1-7
Open Access | Times Cited: 52
Spatial navigation ability predicts progression of dementia symptomatology
Taylor F. Levine, Samantha L. Allison, Marta Stojanovic, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 491-500
Open Access | Times Cited: 42
Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease
Roos J. Jutten, Sietske A.M. Sikkes, Rebecca E. Amariglio, et al.
Journal of the International Neuropsychological Society (2020) Vol. 27, Iss. 5, pp. 426-438
Open Access | Times Cited: 42
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe
Marina Boccardi, Andreas U. Monsch, Clarissa Ferrari, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 1, pp. 29-42
Open Access | Times Cited: 40
Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals
Silvia Ingala, Jori Tomassen, Lyduine E. Collij, et al.
Brain Communications (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top